Gregory Bailey, Director at Biohaven Ltd. (BHVN), bought 200,000 shares at $10.50 ($2.1M) on 2022-10-25, disclosed to the SEC on 2022-10-26.
Open-market purchase of $2.1M BHVN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Something here stands out, but not much.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |